AACR Members: Voting is open through February 28 for AACR President, Board of Directors, and Nominating Committee.

myAACR
Donate Today
Skip to Content

Progress Against Cancer

Home Patients, Caregivers, and Advocates Progress Against Cancer Research

Recent Progress: FDA Approvals

The First Gene Therapy for Bladder Cancer 

The First Gene Therapy for Bladder Cancer 

The FDA approved the adenovirus-based gene therapy nadofaragene firadenovec for the treatment of localized bladder cancer.  The U.S. Food and Drug Administration (FDA) has approved nadofaragene firadenovec (Adstiladrin) for the treatment of adult patients...

Drugging an “Undruggable” Protein 

Drugging an “Undruggable” Protein 

A second inhibitor of the difficult-to-target KRAS protein was approved to treat certain lung cancers.  The U.S. Food and Drug Administration (FDA) has granted accelerated approval to adagrasib (Krazati) for adult patients with locally...